A decent bounce up - then back, though still low volume. The most pleasing thing for me is the increased interest in the stock which can only be positive, combined with new money in @ 25c+. Hit 30c which is where i see it over the next 3mths (unless medivet usa financials come in way above last years guidance).
Half year report due towards the end of Feb - I think it was released on the 28th last year.
MLA Price at posting:
27.0¢ Sentiment: LT Buy Disclosure: Held
